EAP & Limited Use

Please note that the information on this page, including the EAP forms, are outdated and no longer being maintained. We encourage everyone to login to their SADIE (Special Authorization Digital Information Exchange) portal for EAP requests. 

Exceptional Access Program (EAP)

EAP forms are to be completed when applying for MOH funding for drugs for rheumatological diseases through Ontario’s Exceptional Access Program (EAP).

Limited Use Codes

Current LU codes are available online in a database maintained by the Ontario Ministry of Health.

Please visit: https://www.formulary.health.gov.on.ca/formulary/

Note that some drug products not listed on the Formulary are reimbursed through the Exceptional Access Program (EAP). Some drug products listed as a Limited Use benefit on the Formulary may be reimbursed through the EAP for other indications.

ORA Biosimilar Fact Sheet With Limited Use Codes

The ORA maintains a biosimilar fact sheet, complete with LU codes and helpful links. You may access the form here: Biosimilar-Fact-Sheet

NIHB Drug list

Here is a link to the Government of Canada’s Non-Insured Health Benenfits for First Nations and Inuit (NHIB) website.

The CRA has also developed NIHB resources that you may find useful. Link: Non-Insured Health Benefits (NIHB)

Note: Metoject Pre-Filled Syringes (for NIHB only)

November 6, 2019:

The ORA EAP Committee continues to work with the MOHLTC on an approved EAP Form for GCA. We hope to have this completed as soon as possible. A notice will be sent to members once it is available. Thank you for your patience.